GEHLOT, CHUTARARAM NEMARAM – Trademark Portfolio
Entity Type: 01
GEHLOT, CHUTARARAM NEMARAM holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ENEGA, VAKOLA, YAKSHA, and PREM DULHAN. The owner is based in NASHIK MAHARASHTRA.
NAGAR, HIRAWADI ROAD, PANCHAVATI
101, SHREE WHIDE HEIGHTS APT, SARASWATI
NASHIK MAHARASHTRA 422003 , IN
Showing of trademarks Trademarks
Trademark Classifications
GEHLOT, CHUTARARAM NEMARAM's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GEHLOT, CHUTARARAM NEMARAM have?
GEHLOT, CHUTARARAM NEMARAM has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does GEHLOT, CHUTARARAM NEMARAM file in?
GEHLOT, CHUTARARAM NEMARAM files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are GEHLOT, CHUTARARAM NEMARAM's most well-known trademarks?
GEHLOT, CHUTARARAM NEMARAM's registered trademark portfolio includes well-known marks such as ENEGA, VAKOLA, YAKSHA, and PREM DULHAN. These are among 4 currently registered trademarks in the portfolio.
What is GEHLOT, CHUTARARAM NEMARAM's trademark registration success rate?
GEHLOT, CHUTARARAM NEMARAM has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.